Literature DB >> 33184069

Clot Burden Score and Collateral Status and Their Impact on Functional Outcome in Acute Ischemic Stroke.

I Derraz1, M Pou2, J Labreuche3, L Legrand4, S Soize5, M Tisserand6, C Rosso7, M Piotin8, G Boulouis4, C Oppenheim4, O Naggara4, S Bracard9, F Clarençon2, B Lapergue10, R Bourcier11.   

Abstract

BACKGROUND AND
PURPOSE: Collateral status and thrombus length have been independently associated with functional outcome in patients with acute ischemic stroke. It has been suggested that thrombus length would influence functional outcome via interaction with the collateral circulation. We investigated the individual and combined effects of thrombus length assessed by the clot burden score and collateral status assessed by a FLAIR vascular hyperintensity-ASPECTS rating system on functional outcome (mRS).
MATERIALS AND METHODS: Patients with anterior circulation acute ischemic stroke due to large-vessel occlusion from the ASTER and THRACE trials treated with endovascular thrombectomy were pooled. The clot burden score and FLAIR vascular hyperintensity score were determined on MR imaging obtained before endovascular thrombectomy. Favorable outcome was defined as an mRS score of 0-2 at 90 days. Association of the clot burden score and the FLAIR vascular hyperintensity score with favorable outcome (individual effect and interaction) was examined using logistic regression models.
RESULTS: Of the 326 patients treated by endovascular thrombectomy with both the clot burden score and FLAIR vascular hyperintensity assessment, favorable outcome was observed in 165 (51%). The rate of favorable outcome increased with clot burden score (smaller clots) and FLAIR vascular hyperintensity (better collaterals) values. The association between clot burden score and functional outcome was significantly modified by the FLAIR vascular hyperintensity score, and this association was stronger in patients with good collaterals, with an adjusted OR = 6.15 (95% CI, 1.03-36.81).
CONCLUSIONS: The association between the clot burden score and functional outcome varied for different collateral scores. The FLAIR vascular hyperintensity score might be a valuable prognostic factor, especially when contrast-based vascular imaging is not available.
© 2021 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2020        PMID: 33184069      PMCID: PMC7814780          DOI: 10.3174/ajnr.A6865

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  38 in total

Review 1.  Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target.

Authors:  Ashfaq Shuaib; Ken Butcher; Askar A Mohammad; Maher Saqqur; David S Liebeskind
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  Magnetic Resonance Imaging or Computed Tomography Before Treatment in Acute Ischemic Stroke.

Authors:  Corentin Provost; Marc Soudant; Laurence Legrand; Wagih Ben Hassen; Yu Xie; Sébastien Soize; Romain Bourcier; Joseph Benzakoun; Myriam Edjlali; Grégoire Boulouis; Hélène Raoult; Francis Guillemin; Olivier Naggara; Serge Bracard; Catherine Oppenheim
Journal:  Stroke       Date:  2019-03       Impact factor: 7.914

3.  Clot Burden Score on Baseline Computerized Tomographic Angiography and Intra-Arterial Treatment Effect in Acute Ischemic Stroke.

Authors:  Kilian M Treurniet; Albert J Yoo; Olvert A Berkhemer; Hester F Lingsma; Anna M M Boers; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Marieke E S Sprengers; Sjoerd F M Jenniskens; Geert J Lycklama À Nijeholt; Marianne A A van Walderveen; Joseph C J Bot; Ludo F M Beenen; René van den Berg; Wim H van Zwam; Aad van der Lugt; Robert J van Oostenbrugge; Diederik W J Dippel; Yvo B W E M Roos; Henk A Marquering; Charles B L M Majoie
Journal:  Stroke       Date:  2016-11-08       Impact factor: 7.914

4.  Impact of Thrombus Length on Outcomes After Intra-Arterial Aspiration Thrombectomy in the THERAPY Trial.

Authors:  Albert J Yoo; Pooja Khatri; J Mocco; Osama O Zaidat; Rishi Gupta; Donald Frei; Demetrius Lopes; Harish Shownkeen; Olvert A Berkhemer; Denise Meyer; Susana S Hak; Sophia S Kuo; Hope Buell; Arani Bose; Siu Po Sit; Rüdiger von Kummer
Journal:  Stroke       Date:  2017-06-08       Impact factor: 7.914

5.  Thrombus Imaging Characteristics and Outcomes in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment.

Authors:  Bruna G Dutra; Manon L Tolhuisen; Heitor C B R Alves; Kilian M Treurniet; Manon Kappelhof; Albert J Yoo; Ivo G H Jansen; Diederik W J Dippel; Wim H van Zwam; Robert J van Oostenbrugge; Antônio J da Rocha; Hester F Lingsma; Aad van der Lugt; Yvo B W E M Roos; Henk A Marquering; Charles B L M Majoie
Journal:  Stroke       Date:  2019-06-20       Impact factor: 7.914

6.  CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct.

Authors:  I Y L Tan; A M Demchuk; J Hopyan; L Zhang; D Gladstone; K Wong; M Martin; S P Symons; A J Fox; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-15       Impact factor: 3.825

7.  Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials.

Authors:  Sean I Savitz; Robert Lew; Erich Bluhmki; Werner Hacke; Marc Fisher
Journal:  Stroke       Date:  2007-11-01       Impact factor: 7.914

8.  Do FLAIR vascular hyperintensities beyond the DWI lesion represent the ischemic penumbra?

Authors:  L Legrand; M Tisserand; G Turc; O Naggara; M Edjlali; C Mellerio; J-L Mas; J-F Méder; J-C Baron; C Oppenheim
Journal:  AJNR Am J Neuroradiol       Date:  2014-09-04       Impact factor: 3.825

Review 9.  Computed Tomography-Based Thrombus Imaging for the Prediction of Recanalization after Reperfusion Therapy in Stroke.

Authors:  Ji Hoe Heo; Kyeonsub Kim; Joonsang Yoo; Young Dae Kim; Hyo Suk Nam; Eung Yeop Kim
Journal:  J Stroke       Date:  2017-01-31       Impact factor: 6.967

10.  Susceptibility Vessel Sign in the ASTER Trial: Higher Recanalization Rate and More Favourable Clinical Outcome after First Line Stent Retriever Compared to Contact Aspiration.

Authors:  Romain Bourcier; Mickael Mazighi; Julien Labreuche; Robert Fahed; Raphael Blanc; Benjamin Gory; Alain Duhamel; Gaultier Marnat; Suzana Saleme; Vincent Costalat; Serge Bracard; Hubert Desal; Arturo Consoli; Michel Piotin; Bertrand Lapergue
Journal:  J Stroke       Date:  2018-06-29       Impact factor: 6.967

View more
  5 in total

1.  Evaluation of T2-FLAIR combined with ASL on the collateral circulation of acute ischemic stroke.

Authors:  Miaona Zhang; Qiang Shi; Yun Yue; Minfeng Zhang; Lei Zhao; Chengxin Yan
Journal:  Neurol Sci       Date:  2022-04-06       Impact factor: 3.830

Review 2.  Radiology-Pathology Correlations of Intracranial Clots: Current Theories, Clinical Applications, and Future Directions.

Authors:  J C Benson; D F Kallmes; A S Larson; W Brinjikji
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-22       Impact factor: 4.966

3.  BNP on Admission Combined with Imaging Markers of Multimodal CT to Predict the Risk of Cardioembolic Stroke.

Authors:  Ruoyao Cao; Yun Jiang; Ling Li; Yao Lu; Junjie Wang; Kezhen Yu; Min Chen; Juan Chen
Journal:  Dis Markers       Date:  2022-07-26       Impact factor: 3.464

4.  Endovascular Recanalization for Acute Internal Carotid Artery Terminus Occlusion: A Subgroup Analysis From the Direct-MT Trial.

Authors:  Yingying Zhang; Lei Zhang; Yongwei Zhang; Zifu Li; Yongxin Zhang; Pengfei Xing; Wenhuo Chen; Shouchun Wang; Tianxiao Li; Pengfei Yang; Jianmin Liu
Journal:  Neurosurgery       Date:  2022-07-22       Impact factor: 5.315

5.  Heterogeneity of the Relative Benefits of TICI 2c/3 over TICI 2b50/2b67 : Are there Patients who are less Likely to Benefit?

Authors:  Christoph C Kurmann; Adnan Mujanovic; Eike I Piechowiak; Tomas Dobrocky; Felix Zibold; Morin Beyeler; Jan Vynckier; David Seiffge; Thomas R Meinel; Pasquale Mordasini; Marcel Arnold; Urs Fischer; Jan Gralla; Johannes Kaesmacher
Journal:  Clin Neuroradiol       Date:  2022-01-06       Impact factor: 3.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.